NI-0401 in Active Crohn's Disease

NCT00630643 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Crohn's Disease

Interventions

BIOLOGICAL: NI-0401 (anti-CD3 mAB)
DRUG: Placebo

Sponsor

Light Chain Bioscience - Novimmune SA